Lepu Bio

company

About

Lepu Bio is a Innovation-Driven Biopharmaceutical Company.

  • 251 - 500

Details

Last Funding Type
Series B
Last Funding Money Raised
¥1.29B
Industries
Biotechnology,Health Care,Medical,Service Industry,Therapeutics
Founded date
Jan 1, 2018
Number Of Employee
251 - 500
Operating Status
Active

Lepu Bio they have developed an oncology-focused pipeline of drug candidates, including ADCs, oncolytic virus drugs, and immunotherapies at clinical and pre-clinical stages.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
¥2.19B
Lepu Bio has raised a total of ¥2.19B in funding over 2 rounds. Their latest funding was raised on Aug 6, 2020 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 6, 2020 Series B ¥1.29B 2 Detail
Jul 2, 2019 Series A ¥0.90B 1 Detail

Investors

Number of Lead Investors
Number of Investors
3
Lepu Bio is funded by 3 investors. State New Central Enterprises Operating Investment Fund and Haitong Innovation Capital Management are the most recent investors.
Investor Name Lead Investor Funding Round
State New Central Enterprises Operating Investment Fund Series B
Haitong Innovation Capital Management Series B
Sumin Investment Series A